Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Charles River Laboratories International leads the 115 health care companies ranked by P/E ratio, at 366, ahead of Takeda Pharmaceutical (304) and Waters (194). Figures as of 19 Nov 2026, 16:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- First
- Charles River Laboratories International366
- Median
- 30.3
- Combined market value
- ZAR 156.13T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Charles River Laboratories InternationalCRL · Health Care | 366 | ZAR 281.8B | ZAR 5,881.98 | 1.01% up | 106% up | ||
| 2 | Takeda PharmaceuticalTAK · Health Care | 304 | ZAR 1.19T | ZAR 372.18 | 0.14% up | 51% up | ||
| 3 | WatersWAT · Health Care | 194 | ZAR 1.59T | ZAR 8,084.47 | 0.73% down | 23% up | ||
| 4 | Merck & CoMRK · Health Care | 135 | ZAR 5.76T | ZAR 2,334.85 | 3.02% down | 45% up | ||
| 5 | Ligand PharmaceuticalsLGND · Health Care | 117 | ZAR 101.9B | ZAR 5,091.93 | 2.44% down | 50% up | ||
| 6 | BiogenBIIB · Health Care | 107 | ZAR 636.1B | ZAR 4,303.28 | 2.04% down | 49% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | 99.3 | ZAR 175.7B | ZAR 1,162.49 | 0.62% up | 117% up | ||
| 8 | BillionToOneBLLN · Health Care | 98.8 | ZAR 75.9B | ZAR 1,587.78 | 0.73% down | 4% down | ||
| 9 | SolventumSOLV · Health Care | 95.6 | ZAR 252.8B | ZAR 1,487.31 | 1.57% down | 9% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 92.8 | ZAR 813.9B | ZAR 697.53 | 5.47% down | 74% up | ||
| 11 | MedlineMDLN · Health Care | 85.7 | ZAR 866.7B | ZAR 658.56 | 3.75% down | 4% down | ||
| 12 | PenumbraPEN · Health Care | 80.6 | ZAR 220.4B | ZAR 5,591.58 | 0.18% down | 15% up | ||
| 13 | TeleflexTFX · Health Care | 80.5 | ZAR 113.3B | ZAR 2,856.25 | 1.44% down | 58% up | ||
| 14 | ICONICLR · Health Care | 78.6 | ZAR 257.4B | ZAR 3,435.22 | 0.74% up | 23% up | ||
| 15 | LifeStance Health GroupLFST · Health Care | 74.2 | ZAR 88.7B | ZAR 233.35 | 3.01% down | 123% up | ||
| 16 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 71.8 | ZAR 130.1B | ZAR 1,655.84 | 0.30% down | 129% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | 71.4 | ZAR 270.7B | ZAR 4,216.75 | 2.60% down | 41% up | ||
| 18 | RevvityRVTY · Health Care | 68.9 | ZAR 302.4B | ZAR 2,708.60 | 1.70% up | 62% up | ||
| 19 | HeartflowHTFL · Health Care | 68.3 | ZAR 70.3B | ZAR 799.40 | 0.31% down | 66% up | ||
| 20 | Bio-TechneTECH · Health Care | 66.7 | ZAR 199.6B | ZAR 1,270.32 | 0.07% down | 24% up | ||
| 21 | Edwards LifesciencesEW · Health Care | 60.7 | ZAR 1.05T | ZAR 1,823.06 | 0.85% down | 25% up | ||
| 22 | IncyteINCY · Health Care | 59.4 | ZAR 414.7B | ZAR 2,034.48 | 1.16% down | 16% up | ||
| 23 | AlconALC · Health Care | 55.0 | ZAR 632.6B | ZAR 1,316.78 | 0.13% up | 0% up | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 53.5 | ZAR 130.2B | ZAR 373.66 | 2.26% down | 90% up | ||
| 25 | HaemoneticsHAE · Health Care | 53.0 | ZAR 95.3B | ZAR 2,092.76 | 2.52% down | 64% up | ||
| 26 | BeOne MedicinesONC · Health Care | 51.6 | ZAR 803.1B | ZAR 7,030.66 | 0.30% down | 16% up | ||
| 27 | Intuitive SurgicalISRG · Health Care | 50.4 | ZAR 2.52T | ZAR 7,282.80 | 0.99% down | 24% down | ||
| 28 | Corcept TherapeuticsCORT · Health Care | 49.5 | ZAR 125.9B | ZAR 1,150.04 | 2.91% down | 10% down | ||
| 29 | AbbVieABBV · Health Care | 48.3 | ZAR 8.67T | ZAR 4,907.50 | 1.80% down | 25% up | ||
| 30 | IDEXX LaboratoriesIDXX · Health Care | 46.6 | ZAR 951.8B | ZAR 12,081.27 | 1.01% down | 1% up | ||
| 31 | BrightSpring Health ServicesBTSG · Health Care | 46.5 | ZAR 227.9B | ZAR 1,145.36 | 4.08% down | 109% up | ||
| 32 | West Pharmaceutical ServicesWST · Health Care | 44.9 | ZAR 486.5B | ZAR 6,983.40 | 1.08% down | 57% up | ||
| 33 | GenmabGMAB · Health Care | 44.5 | ZAR 560.3B | ZAR 908.78 | 2.04% up | 70% up | ||
| 34 | Royalty PharmaRPRX · Health Care | 44.3 | ZAR 680.6B | ZAR 1,183.72 | 1.35% down | 79% up | ||
| 35 | Eli LillyLLY · Health Care | 43.8 | ZAR 21.01T | ZAR 23,585.58 | 2.38% down | 33% up | ||
| 36 | Krystal BiotechKRYS · Health Care | 42.4 | ZAR 161.6B | ZAR 5,454.41 | 1.01% down | 54% up | ||
| 37 | Becton, DickinsonBDX · Health Care | 41.9 | ZAR 1.01T | ZAR 3,706.23 | 1.84% down | 45% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.2 | ZAR 216.2B | ZAR 259.30 | 0.93% down | 8% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | 40.2 | ZAR 11.15T | ZAR 4,630.38 | 2.82% down | 34% up | ||
| 40 | PfizerPFE · Health Care | 39.4 | ZAR 2.75T | ZAR 481.73 | 1.75% down | 15% up | ||
| 41 | Abbott LaboratoriesABT · Health Care | 39.0 | ZAR 3.16T | ZAR 1,826.20 | 0.03% up | 16% down | ||
| 42 | DanaherDHR · Health Care | 37.7 | ZAR 2.8T | ZAR 3,980.73 | 0.33% down | 3% up | ||
| 43 | Mettler-Toledo InternationalMTD · Health Care | 37.3 | ZAR 596.8B | ZAR 30,004.25 | 1.16% down | 24% up | ||
| 44 | HumanaHUM · Health Care | 37.2 | ZAR 800.4B | ZAR 6,664.43 | 1.13% down | 73% up | ||
| 45 | Thermo Fisher ScientificTMO · Health Care | 36.7 | ZAR 4.51T | ZAR 12,168.38 | 0.53% up | 21% up | ||
| 46 | IlluminaILMN · Health Care | 36.5 | ZAR 560.4B | ZAR 3,706.05 | 1.00% up | 76% up | ||
| 47 | Medpace HoldingsMEDP · Health Care | 35.6 | ZAR 313.1B | ZAR 11,195.21 | 0.95% down | 10% up | ||
| 48 | Cardinal HealthCAH · Health Care | 35.3 | ZAR 1.1T | ZAR 4,765.53 | 2.01% down | 34% up | ||
| 49 | Agilent TechnologiesA · Health Care | 35.2 | ZAR 878.6B | ZAR 3,115.98 | 0.56% up | 22% up | ||
| 50 | HealthEquityHQY · Health Care | 34.8 | ZAR 139.3B | ZAR 1,683.71 | 0.98% down | 3% down | ||
| 51 | Vertex PharmaceuticalsVRTX · Health Care | 33.7 | ZAR 2.32T | ZAR 9,161.51 | 2.26% down | 27% up | ||
| 52 | StrykerSYK · Health Care | 33.4 | ZAR 2.09T | ZAR 5,481.32 | 1.40% down | 12% down | ||
| 53 | argenxARGX · Health Care | 32.5 | ZAR 1.03T | ZAR 16,410.59 | 0.22% down | 2% up | ||
| 54 | DexComDXCM · Health Care | 31.9 | ZAR 527.5B | ZAR 1,414.36 | 1.91% down | 41% up | ||
| 55 | Merit Medical SystemsMMSI · Health Care | 31.6 | ZAR 88.4B | ZAR 1,475.78 | 1.71% down | 1% up | ||
| 56 | IQVIA HoldingsIQV · Health Care | 31.1 | ZAR 735B | ZAR 4,460.02 | 1.00% down | 19% up | ||
| 57 | AvantorAVTR · Health Care | 30.6 | ZAR 180.9B | ZAR 266.99 | 0.58% down | 40% up | ||
| 58 | Labcorp HoldingsLH · Health Care | 30.3 | ZAR 523.7B | ZAR 6,449.86 | 0.45% down | 42% up | ||
| 59 | STERISSTE · Health Care | 30.1 | ZAR 430.5B | ZAR 4,432.76 | 2.27% down | 1% up | ||
| 60 | NovartisNVS · Health Care | 28.9 | ZAR 4.99T | ZAR 2,642.33 | 2.57% down | 25% up | ||
| 61 | McKessonMCK · Health Care | 27.0 | ZAR 2.12T | ZAR 18,318.65 | 3.32% down | 28% up | ||
| 62 | QiagenQGEN · Health Care | 26.8 | ZAR 179B | ZAR 866.93 | 0.11% up | 9% up | ||
| 63 | Protagonist TherapeuticsPTGX · Health Care | 26.7 | ZAR 144.3B | ZAR 2,210.26 | 0.52% down | 51% up | ||
| 64 | Ensign GroupENSG · Health Care | 26.6 | ZAR 182.1B | ZAR 3,121.23 | 2.38% down | 2% up | ||
| 65 | LivaNovaLIVN · Health Care | 26.5 | ZAR 89.1B | ZAR 1,617.66 | 2.07% down | 77% up | ||
| 66 | ChemedCHE · Health Care | 26.1 | ZAR 123.3B | ZAR 9,513.07 | 0.42% down | 27% up | ||
| 67 | Zimmer Biomet HoldingsZBH · Health Care | 26.0 | ZAR 340.8B | ZAR 1,800.69 | 0.26% down | 16% up | ||
| 68 | Quest DiagnosticsDGX · Health Care | 25.8 | ZAR 498.3B | ZAR 4,529.04 | 0.19% down | 38% up | ||
| 69 | Koninklijke PhilipsPHG · Health Care | 25.6 | ZAR 503.4B | ZAR 514.93 | 1.14% down | 12% up | ||
| 70 | AmgenAMGN · Health Care | 25.4 | ZAR 4.14T | ZAR 7,658.56 | 1.26% down | 32% up | ||
| 71 | Lantheus HoldingsLNTH · Health Care | 25.4 | ZAR 116.6B | ZAR 1,782.61 | 0.02% up | 90% up | ||
| 72 | AstraZenecaAZN · Health Care | 24.6 | ZAR 4.72T | ZAR 3,044.08 | 2.54% down | 1% up | ||
| 73 | MedtronicMDT · Health Care | 24.6 | ZAR 2.24T | ZAR 1,749.41 | 0.60% down | 1% up | ||
| 74 | Concentra Group Holdings ParentCON · Health Care | 24.5 | ZAR 90.8B | ZAR 722.34 | 1.38% down | 116% up | ||
| 75 | PACS GroupPACS · Health Care | 24.2 | ZAR 118.3B | ZAR 745.63 | 7.83% down | 77% up | ||
| 76 | Neurocrine BiosciencesNBIX · Health Care | 23.6 | ZAR 281.5B | ZAR 2,781.11 | 2.27% down | 17% up | ||
| 77 | Align TechnologyALGN · Health Care | 23.6 | ZAR 199.2B | ZAR 2,825.58 | 1.37% down | 23% up | ||
| 78 | Halozyme TherapeuticsHALO · Health Care | 23.2 | ZAR 184.7B | ZAR 1,620.11 | 3.22% down | 39% up | ||
| 79 | Henry ScheinHSIC · Health Care | 23.1 | ZAR 162.8B | ZAR 1,472.98 | 1.62% down | 20% up | ||
| 80 | Option Care HealthOPCH · Health Care | 22.9 | ZAR 82.7B | ZAR 552.33 | 0.32% down | 12% up | ||
| 81 | SanofiSNY · Health Care | 22.8 | ZAR 1.92T | ZAR 800.01 | 2.83% down | 4% down | ||
| 82 | MSA SafetyMSA · Health Care | 22.7 | ZAR 118.8B | ZAR 3,085.06 | 0.50% down | 16% up | ||
| 83 | InsuletPODD · Health Care | 22.4 | ZAR 166.5B | ZAR 2,399.50 | 1.90% down | 55% down | ||
| 84 | CenteneCNC · Health Care | 22.4 | ZAR 562.8B | ZAR 1,136.80 | 3.54% down | 94% up | ||
| 85 | ResMedRMD · Health Care | 21.5 | ZAR 581.1B | ZAR 4,131.43 | 2.54% down | 1% down | ||
| 86 | United TherapeuticsUTHR · Health Care | 21.3 | ZAR 420.3B | ZAR 9,868.65 | 2.17% down | 22% up | ||
| 87 | Encompass HealthEHC · Health Care | 21.0 | ZAR 224.5B | ZAR 2,288.11 | 2.95% down | 20% up | ||
| 88 | Regeneron PharmaceuticalsREGN · Health Care | 20.6 | ZAR 1.68T | ZAR 16,282.16 | 1.45% down | 28% up | ||
| 89 | Cooper CompaniesCOO · Health Care | 20.6 | ZAR 198.9B | ZAR 1,045.77 | 1.48% down | 15% down | ||
| 90 | Smith & NephewSNN · Health Care | 20.4 | ZAR 218.7B | ZAR 523.15 | 1.25% down | 5% down | ||
| 91 | ExelixisEXEL · Health Care | 19.7 | ZAR 280.5B | ZAR 1,149.73 | 3.65% down | 63% up | ||
| 92 | UnitedHealth GroupUNH · Health Care | 18.9 | ZAR 5.19T | ZAR 5,789.04 | 5.32% down | 12% up | ||
| 93 | CencoraCOR · Health Care | 18.9 | ZAR 1.13T | ZAR 5,929.77 | 2.57% down | 4% down | ||
| 94 | Boston ScientificBSX · Health Care | 18.2 | ZAR 1.1T | ZAR 755.71 | 0.89% down | 55% down | ||
| 95 | Ascendis PharmaASND · Health Care | 17.4 | ZAR 304.1B | ZAR 4,635.27 | 1.87% down | 29% up | ||
| 96 | GE HealthCare TechnologiesGEHC · Health Care | 17.4 | ZAR 648.7B | ZAR 1,434.72 | 1.85% down | 12% up | ||
| 97 | Globus MedicalGMED · Health Care | 17.1 | ZAR 160.5B | ZAR 1,211.24 | 1.72% down | 14% down | ||
| 98 | GSKGSK · Health Care | 16.6 | ZAR 1.67T | ZAR 834.87 | 1.65% down | 5% up | ||
| 99 | Elevance HealthELV · Health Care | 16.5 | ZAR 1.47T | ZAR 6,783.16 | 3.15% down | 28% up | ||
| 100 | HCA HealthcareHCA · Health Care | 15.3 | ZAR 1.69T | ZAR 8,066.47 | 3.09% down | 0% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4731 ZAR). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/E ratio?
Charles River Laboratories International (366), Takeda Pharmaceutical (304) and Waters (194) are the top three of the 115 health care companies ranked by P/E ratio as of 19 Nov 2026, 16:24 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of ZAR 156.13T as of 19 Nov 2026, 16:24 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.